[go: up one dir, main page]

NO943288L - Anvendelse av pentoksyfyllin ved fremstilling av farmasöytiske preparater til behandling av granulomatöse og fibroserende lungesykdommer - Google Patents

Anvendelse av pentoksyfyllin ved fremstilling av farmasöytiske preparater til behandling av granulomatöse og fibroserende lungesykdommer

Info

Publication number
NO943288L
NO943288L NO943288A NO943288A NO943288L NO 943288 L NO943288 L NO 943288L NO 943288 A NO943288 A NO 943288A NO 943288 A NO943288 A NO 943288A NO 943288 L NO943288 L NO 943288L
Authority
NO
Norway
Prior art keywords
pentoxyphylline
granulomatosis
treatment
lung disease
preparation
Prior art date
Application number
NO943288A
Other languages
English (en)
Other versions
NO943288D0 (no
Inventor
Peter Zabel
Ulrich Schade
Original Assignee
Rentschler Arzneimittel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rentschler Arzneimittel filed Critical Rentschler Arzneimittel
Publication of NO943288D0 publication Critical patent/NO943288D0/no
Publication of NO943288L publication Critical patent/NO943288L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Det er beskrevet anvendelsen av pentoksyfyllin, eventuelt i kombinasjon med ytterligere terapeu- tiske virkestoffer ved fremstilling av farmasøytis- ke preparater til behandling av granulomatese og fibroserende lungesykdommer.
NO943288A 1993-09-21 1994-09-06 Anvendelse av pentoksyfyllin ved fremstilling av farmasöytiske preparater til behandling av granulomatöse og fibroserende lungesykdommer NO943288L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4332041A DE4332041C2 (de) 1993-09-21 1993-09-21 Verwendung von Pentoxifyllin bei bestimmten Lungenerkrankungen

Publications (2)

Publication Number Publication Date
NO943288D0 NO943288D0 (no) 1994-09-06
NO943288L true NO943288L (no) 1995-03-22

Family

ID=6498198

Family Applications (1)

Application Number Title Priority Date Filing Date
NO943288A NO943288L (no) 1993-09-21 1994-09-06 Anvendelse av pentoksyfyllin ved fremstilling av farmasöytiske preparater til behandling av granulomatöse og fibroserende lungesykdommer

Country Status (7)

Country Link
EP (1) EP0670163A1 (no)
JP (1) JPH07247215A (no)
CZ (1) CZ230094A3 (no)
DE (1) DE4332041C2 (no)
HU (1) HUT70054A (no)
NO (1) NO943288L (no)
SK (1) SK111894A3 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6294350B1 (en) * 1997-06-05 2001-09-25 Dalhousie University Methods for treating fibroproliferative diseases
FR2779063A1 (fr) * 1998-05-29 1999-12-03 Assist Publ Hopitaux De Paris Compositions a base de pentoxifylline et leur utilisation therapeutique
AR029189A1 (es) * 1999-11-02 2003-06-18 Smithkline Beecham Corp Uso de un inhibidor de fosfodiesterasa 4 y un corticoesteroide antiinflamatorio en forma combinada, separadamente o separadamente secuencial para la preparacion de un medicamento
WO2001095938A1 (fr) * 2000-06-16 2001-12-20 Chugai Seiyaku Kabushiki Kaisha Medicaments preventifs et therapeutiques destines au granulome
US20060083714A1 (en) * 2003-01-27 2006-04-20 Warner James M Combination of a pde iv inhibitor and a tnf-alpha antagonist
WO2006035418A2 (en) * 2004-09-27 2006-04-06 Sigmoid Biotechnologies Limited Microcapsules comprising a methylxanthine and a corticosteroid
DK2079456T3 (da) 2007-04-04 2013-03-18 Sigmoid Pharma Ltd Farmaceutiske cyclosporinsammensætninger
BRPI1012196B1 (pt) 2009-05-18 2021-11-30 Sublimity Therapeutics Limited Composição compreendendo gotas de óleo
EP2464341B1 (en) 2009-08-12 2022-07-06 Sublimity Therapeutics Limited Immunomodulatory compositions comprising a polymer matrix and an oil phase
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201304662D0 (en) 2013-03-14 2013-05-01 Sigmoid Pharma Ltd Compositions
KR101512223B1 (ko) * 2013-02-22 2015-04-24 가톨릭대학교 산학협력단 펜톡시필린을 포함하는 항암치료 보조제
KR20170102223A (ko) 2014-11-07 2017-09-08 시그모이드 파마 리미티드 사이클로스포린을 포함하는 조성물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192528A (en) * 1985-05-22 1993-03-09 Liposome Technology, Inc. Corticosteroid inhalation treatment method

Also Published As

Publication number Publication date
JPH07247215A (ja) 1995-09-26
NO943288D0 (no) 1994-09-06
DE4332041C2 (de) 1997-12-11
SK111894A3 (en) 1995-05-10
HU9402709D0 (en) 1995-02-28
HUT70054A (en) 1995-09-28
DE4332041A1 (de) 1995-03-23
EP0670163A1 (de) 1995-09-06
CZ230094A3 (en) 1995-04-12

Similar Documents

Publication Publication Date Title
IL195723A (en) Use of p53 inhibitors for the preparation of medicament
BG101118A (en) Therapeutical compounds
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
MY111260A (en) Pharmaceutical composition for the treatment of nicotine dependence
GEP20063799B (en) Tropane derivatives useful in therapy
MY119403A (en) Novel compounds with analgesic effect.
NO954878L (no) Pyrrolderivater
IS1907B (is) Notkun klóbindiefnisins klíókínól við að framleiða lyfjablöndu til að meðhöndla Alzheimers-sjúkdóm
NO954996D0 (no) Anvendelse av nona- og dekapeptider for fremstilling av et legemiddel for behandling av AIDS
NO952309L (no) Anvendelse av riluzol ved behandling av Parkinsons sykdom og Parkinsonske syndromer
GB9806632D0 (en) Peptide factor
NO943288L (no) Anvendelse av pentoksyfyllin ved fremstilling av farmasöytiske preparater til behandling av granulomatöse og fibroserende lungesykdommer
HK1021539A1 (en) Androstene derivatives.
NO972391L (no) 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav
NO994165L (no) Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet
WO1998009599A3 (fr) Utilisation d'un nouvel acide bicafeoylquinique dans le traitement de l'hepatite b et des maladies liees a des retrovirus, et derives de cet acide bicafeolyquinique
DE69200711D1 (de) Pharmazeutische Zusammensetzungen enthaltend Fluticasonpropionat und Oxikonazol oder dessen Salz zur lokalen Anwendung.
ATE139226T1 (de) Aminosulfonylharnstoff-acat-inhibitoren
HUP9802897A3 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient
ATE271852T1 (de) Verbesserte inhalationspräparate
MXPA04001912A (es) Aminobenzofenonas novedosas.
MXPA02011533A (es) Nuevas formulaciones de alfa-2,4-disulfofenil-n-terc-butilnitrona.
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
AU1604592A (en) New 2-amino-5-cyano-1,4-dihydropyridines, processes for their preparation and their use in medicaments
EP0795332A3 (en) Medical use of gamma-interferon in interstitial lung diseases